Table 1.

Clinical and pathological characteristics of patients in 4 surgery groups

Variable	VEOP N = 50	RHOP N = 84	VEBO N = 9	RHBO N = 62	P value
Age (years)	36.36 ± 4.34	38.92 ± 4.87	44.73 ± 4.62	51.69 ± 7.29	.000
Menstruation					.000
Regular	49 (98%)	83 (97.6%)	6 (75.0%)	19 (30.6%)
Irregular	1 (2.0%)	2 (2.4%)	0 (0.0%)	7 (11.3%)
Menopause	0 (0%)	0 (0%)	2 (25.0%)	36 (58.1%)
FIGO stage					.002
Ia1	0 (0.0%)	9 (10.6%)	0 (0.0%)	0 (0.0%)
Ia2	1 (2.0%)	5 (5.9%)	0 (0.0%)	0 (0.0%)
Ib1	36 (72.0%)	49 (57.6%)	6 (75.0%)	34 (54.8%)
Ib2	6 (12.0%)	10 (11.8%)	1 (12.5%)	5 (8.1%)
IIa1	4 (8.0%)	5 (5.9%)	0 (0.0%)	17 (27.4%)
IIa2	3 (6.0%)	7 (8.2%)	1 (12.5%)	6 (9.7%)
Operating time (min)	255.22 ± 48.74	230.67 ± 44.09	237.33 ± 10.72	217.31 ± 69.80	.003
Amount of blood loss (mL)	276.00 ± 231.95	291.29 ± 167.94	293.75 ± 56.3	249.65 ± 96.03	.505
Length of resected vaginal wall (cm)
At 12 o'clock	2.53 ± 0.67	2.62 ± 0.93	2.69 ± 0.39	2.60 ± 0.72	.920
At 3 o'clock	2.65 ± 0.68	2.69 ± 0.90	2.55 ± 0.92	2.49 ± 0.64	.444
At 6 o'clock	3.48 ± 0.89	3.22 ± 1.06	3.60 ± 1.12	3.13 ± 0.80	.178
At 9 o'clock	2.54 ± 0.61	2.71 ± 0.90	2.79 ± 0.90	2.44 ± 0.67	.127
Hospital stay(days)	18.62 ± 5.47	16.96 ± 4.42	17.50 ± 4.47	17.94 ± 5.12	.285
Postoperative adjuvant therapy					.160
None	34 (68.0%)	50 (58.8%)	4 (50.0%)	35 (56.5%)
Chemotherapy only	0 (0.0%)	8 (9.4%)	0 (0.0%)	3 (4.8%)
Radiotherapy only	0 (0.0%)	7 (8.2%)	1 (12.5%)	3 (4.8%)
Chemoradiotherapy	16 (32.0%)	20 (23.5%)	3 (37.5%)	21 (33.9%)
Length of vagina measured 1 year after surgery (cm)	7.24 ± 0.66	5.12 ± 0.64	7.51 ± 0.33	4.69 ± 0.57	.000
Number of recurrence by the last follow-up	3 (6.0%)	1 (1.2%)	1 (12.5%)	0 (0.0%)	.042
Number of death by the last follow-up	0 (0.0%)	1 (1.2%)	0 (0.0%)	0 (0.0%)	.701
Postoperative sexual life					.000
Yes	42 (84.0%)	68 (80.0%)	4 (50.0%)	18 (29.0%)
No	8 (16.0%)	17 (20.0%)	4 (50.0%)	44 (71.0%)
Divorce after surgery	3 (6.0%)	2 (2.4%)	0 (0.0%)	1 (1.6%)	.498